Latest Commercial Readiness News

Metallium Ltd has revealed significant progress in commercialising its Flash Joule Heating technology with a new Texas facility and key partnerships, setting the stage for global expansion in critical metals recovery.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Elsight’s Halo platform has advanced to the final phase of a major U.S. Defense Innovation Unit challenge, securing significant funding and positioning the company at the forefront of a generational unmanned systems investment cycle.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

IperionX rebuffs short seller claims by highlighting robust US government support and accelerating titanium production scale-up in Virginia. The company secures over $59 million in funding and advances critical minerals projects toward commercial readiness.

Optiscan Imaging has entered a three-year strategic collaboration with Australian Clinical Labs to validate and deploy its InForm™ digital pathology platform, aiming to transform diagnostic workflows with real-time tissue analysis.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

Global Uranium and Snow Lake Resources have agreed to merge, creating a leading US-focused uranium developer with a diversified project portfolio. The announcement also highlights a maiden high-grade resource at Maybell and ongoing promising drilling at Pine Ridge.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Lithium Universe Limited has secured exclusive rights to a breakthrough silver extraction technology from Macquarie University, promising high-purity silver recovery from solar panels while preserving valuable silicon wafers. This innovation complements their existing recycling and lithium refining strategies in North America.

Locksley Resources appoints Kerrie Matthews as Managing Director and CEO to spearhead the commercialisation of U.S.-produced antimony, following a landmark domestic metal ingot milestone.

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.